Pasithea Therapeutics
$0.77
10
+$0.03+3.48% Thursday 20:00
Statistics
Day High
0.78
Day Low
0.69
52W High
3.79
52W Low
0.28
Volume
291,175
Avg. Volume
285,390
Mkt Cap
5.73M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-27.81MNet Income
Analyst Ratings
$3.00Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KTTA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Axsome Therapeutics
AXSM
Mkt Cap6.74B
BridgeBio Pharma
BBIO
Mkt Cap12.07B
Alkermes
ALKS
Mkt Cap5.07B
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
Biogen
BIIB
Mkt Cap22.63B
AMGEN
AMGN
Mkt Cap160.66B
Jazz Pharmaceuticals
JAZZ
Mkt Cap8.35B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Novartis
NVS
Mkt Cap237.61B
About
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Show more...
CEO
Dr. Lawrence Steinman BA, M.D., Ph.D.
Employees
4
Country
US
ISIN
US70261F2020
Listings
0 Comments
Share your thoughts
FAQ
What is Pasithea Therapeutics stock price today?▼
The current price of KTTA is $0.77 USD — it has increased by +3.48% in the past 24 hours. Watch Pasithea Therapeutics stock price performance more closely on the chart.
What is Pasithea Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pasithea Therapeutics stocks are traded under the ticker KTTA.
Is Pasithea Therapeutics stock price growing?▼
KTTA stock has risen by +4.04% compared to the previous week, the month change is a -3.76% fall, over the last year Pasithea Therapeutics has showed a -39.38% decrease.
What is Pasithea Therapeutics market cap?▼
Today Pasithea Therapeutics has the market capitalization of 5.73M
When is the next Pasithea Therapeutics earnings date?▼
Pasithea Therapeutics is going to release the next earnings report on June 03, 2026.
What were Pasithea Therapeutics earnings last quarter?▼
KTTA earnings for the last quarter are -0.18 USD per share, whereas the estimation was -0.18 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pasithea Therapeutics revenue for the last year?▼
Pasithea Therapeutics revenue for the last year amounts to 0 USD.
What is Pasithea Therapeutics net income for the last year?▼
KTTA net income for the last year is -27.81M USD.
How many employees does Pasithea Therapeutics have?▼
As of April 03, 2026, the company has 4 employees.
In which sector is Pasithea Therapeutics located?▼
Pasithea Therapeutics operates in the Health Care sector.
When did Pasithea Therapeutics complete a stock split?▼
The last stock split for Pasithea Therapeutics was on January 02, 2024 with a ratio of 1:20.
Where is Pasithea Therapeutics headquartered?▼
Pasithea Therapeutics is headquartered in Miami Beach, US.